PAWZ vs. THNR ETF Comparison
Comparison of ProShares Pet Care ETF (PAWZ) to Amplify Weight Loss Drug & Treatment ETF (THNR)
PAWZ
ProShares Pet Care ETF
PAWZ Description
The investment seeks investment results, before fees and expenses, that track the performance of the FactSet Pet Care EW Index (the "index"). The fund seeks to invest substantially all of its assets in the stocks that make up the index. Under normal circumstances, the fund will invest at least 80% of its total assets in the component securities of the index. The index consists of U.S. and international companies that potentially stand to benefit from interest in, resources spent on, pet ownership. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$55.87
Average Daily Volume
3,098
17
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$22.71
Average Daily Volume
2,561
15
Performance
Period | PAWZ | THNR |
---|---|---|
30 Days | -5.02% | -14.51% |
60 Days | -7.54% | -17.90% |
90 Days | -1.15% | -17.51% |
12 Months | 20.54% |
1 Overlapping Holdings
Symbol | Grade | Weight in PAWZ | Weight in THNR | Overlap | |
---|---|---|---|---|---|
MRK | F | 4.37% | 4.79% | 4.37% |
PAWZ: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords